The invention provides a compound
DOTA-HX2-DZ and application thereof, and belongs to the technical field of biological
medicine. According to the invention, the molecular structure of DZ-HX2-
DOTA is optimized, and a special
connexon is designed and adopted, so that the problem of limited anti-tumor
curative effect caused by poorer stability,
fat solubility, tumor
residence time and other properties of a radiolabeled
drug in the prior art is solved. The compound provided by the invention can significantly reduce the risk of
label removal of radioactive
metal ions in an in-vivo environment, and ensures that the compound stably plays a role at a targeted part; the compound has excellent molecular lipid
solubility, can penetrate
cell membranes and vascular barriers more easily, improves the
bioavailability of drugs, prolongs the in-vivo
circulation time, prolongs the tumor
residence time, and further improves the treatment efficiency. The DZ-HX2-
DOTA disclosed by the invention has broad-spectrum
tumor targeting property, and can be used for diagnosing and treating various types of malignant tumors.